Abiopharma

🔍 Winningham Rick E (Executive)

Company: Theravance Biopharma, Inc. (TBPH)

Report Date: 2025-08-20

Detailed Transactions and Holdings:

• Sold 15,394 shares of Ordinary Shares at $13.39 per share (Direct)
  Date: 2025-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,717,786.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2025-08-20 | Code: H | nature_of_ownership: As Custodian | shares_owned_after: 13,500.00
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2025-08-20 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 92,567.00

Footnotes:

• F1: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.